Bristol Myers Squibb to invest $400 million in Dublin campus

The investment will lead to the creation of 350 jobs by 2026, Bristol Myers Squibb said

An artist’s impression of the new Dublin facility. Picture: Bristol Myers Squibb

Bristol Myers Squibb is to invest $400 million in its Dublin Cruisepath campus with the creation of 350 jobs.

The investment will go towards the creation of sterile drug product facility, which will support the manufacturing and supply of existing medicines as well as serve as a launch excellence facility for pipeline assets.

The facility will be Bristol Myers Squibb’s first such European sterile drug product facility for biologics manufacturing.

Padraig Keane, the vice president ...